{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:11:35Z","timestamp":1779376295298,"version":"3.53.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"am","delay-in-days":261,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K27339"],"award-info":[{"award-number":["JP23K27339"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K24044"],"award-info":[{"award-number":["JP23K24044"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117230","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T06:39:58Z","timestamp":1755067198000},"page":"117230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Role of organic anion transporter 2 in the efflux of raltegravir glucuronide from the endoplasmic reticulum in the liver"],"prefix":"10.1016","volume":"242","author":[{"given":"Shengyu","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-7646","authenticated-orcid":false,"given":"Hiroshi","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2025.117230_b0005","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","article-title":"The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification","volume":"45","author":"Rowland","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117230_b0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI915","article-title":"Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes","volume":"101","author":"Iyer","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117230_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.44.101802.121546","article-title":"Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches","volume":"44","author":"Miners","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117230_b0020","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1124\/dmd.109.027227","article-title":"Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers","volume":"37","author":"Izukawa","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2025.117230_b0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1081\/DMR-100101944","article-title":"Structural and functional studies of UDP-glucuronosyltransferases","volume":"31","author":"Radominska-Pandya","year":"1999","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bcp.2025.117230_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116322","article-title":"Endoplasmic reticulum transporter OAT2 regulates drug metabolism and interaction","volume":"225","author":"Arakawa","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117230_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113916","article-title":"SLC35B1 significantly contributes to the uptake of UDPGA into the endoplasmic reticulum for glucuronidation catalyzed by UDP-glucuronosyltransferases","volume":"175","author":"Ondo","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117230_b0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/dmd.116.074294","article-title":"Quantitative prediction of human renal clearance and drug-drug interactions of organic anion transporter substrates using in vitro transport data: a relative activity factor approach","volume":"45","author":"Mathialagan","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2025.117230_b0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.dmpk.2016.09.004","article-title":"Human organic anion transporter 2 is an entecavir, but not tenofovir, transporter","volume":"32","author":"Furihata","year":"2017","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.bcp.2025.117230_b0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/dmd.111.042036","article-title":"Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs","volume":"40","author":"Cheng","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2025.117230_b0055","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1248\/bpb.33.498","article-title":"Renal secretion of uric acid by organic anion transporter 2 (OAT2\/SLC22A7) in human","volume":"33","author":"Sato","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bcp.2025.117230_b0060","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117230_b0065","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1124\/dmd.116.072066","article-title":"Abundance of drug transporters in the human kidney cortex as quantified by quantitative targeted proteomics","volume":"44","author":"Prasad","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2025.117230_b0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1124\/mol.107.043117","article-title":"Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP","volume":"73","author":"Cropp","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117230_b0075","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1124\/dmd.107.016196","article-title":"Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme","volume":"35","author":"Kassahun","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2025.117230_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112838","article-title":"Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS\/MS with application in a maternal-fetal pharmacokinetic study","volume":"177","author":"Moreira","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"Suppl. 3","key":"10.1016\/j.bcp.2025.117230_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2047-783X-14-S3-17","article-title":"Drug-drug interactions with raltegravir","volume":"14","author":"Burger","year":"2009","journal-title":"Eur. J. Med. Res."},{"issue":"38","key":"10.1016\/j.bcp.2025.117230_b0090","doi-asserted-by":"crossref","first-page":"11200","DOI":"10.1021\/jp504886u","article-title":"Alamethicin disrupts the cholesterol distribution in dimyristoyl phosphatidylcholine-cholesterol lipid bilayers","volume":"118","author":"Qian","year":"2014","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.bcp.2025.117230_b0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1208\/s12248-013-9554-7","article-title":"Use of different parameters and equations for calculation of IC50 values in efflux assays: potential sources of variability in IC50 determination","volume":"16","author":"Volpe","year":"2014","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.bcp.2025.117230_b0100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1211\/0022357055966","article-title":"Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7])","volume":"57","author":"Kobayashi","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117230_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"9","key":"10.1016\/j.bcp.2025.117230_b0110","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.bcp.2008.12.004","article-title":"Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions","volume":"77","author":"Bock","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117230_b0115","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/bio.4392","article-title":"A fast fluorescent probe for tracing endoplasmic reticulum-located carboxylesterase in living cells","volume":"37","author":"Dai","year":"2022","journal-title":"Lumin. J. Biol. Chem. Lumin."},{"issue":"6","key":"10.1016\/j.bcp.2025.117230_b0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2018-01-830901","article-title":"Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition","volume":"132","author":"Wu","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2025.117230_b0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/dmd.107.018705","article-title":"Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates","volume":"36","author":"Fujiwara","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2025.117230_b0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/clpt.1993.5","article-title":"Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance","volume":"53","author":"Cloyd","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117230_b0135","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/clpt.1994.137","article-title":"Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus","volume":"56","author":"Lertora","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117230_b0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1012840717735","article-title":"Psychopharmacological treatment of patients with HIV and AIDS","volume":"73","author":"Ferrando","year":"2002","journal-title":"Psychiatr. Q."},{"issue":"4","key":"10.1016\/j.bcp.2025.117230_b0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1479-7364-4-4-238","article-title":"The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions","volume":"4","author":"Marques","year":"2010","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.bcp.2025.117230_b0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/bdd.2043","article-title":"Atazanavir increases the plasma concentrations of 1200 mg raltegravir dose","volume":"37","author":"Krishna","year":"2016","journal-title":"Biopharm. Drug Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2025.117230_b0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/INF.0000000000003364","article-title":"Raltegravir-based postnatal HIV prophylaxis therapy in a neonate after in utero dolutegravir exposure","volume":"41","author":"Jacobs","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.bcp.2025.117230_b0160","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cpt.2980","article-title":"Understanding statin-roxadustat drug-drug-disease interaction using physiologically-based pharmacokinetic modeling","volume":"114","author":"Dong","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117230_b0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40262-023-01241-7","article-title":"Estimation of FMO3 ontogeny by mechanistic population pharmacokinetic modelling of risdiplam and its impact on drug-drug interactions in children","volume":"62","author":"Cleary","year":"2023","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.bcp.2025.117230_b0170","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s12272-017-0976-0","article-title":"Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling","volume":"40","author":"Min","year":"2017","journal-title":"Arch. Pharm. Res."},{"issue":"22","key":"10.1016\/j.bcp.2025.117230_b0175","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1002\/pmic.201000289","article-title":"Subcellular fractionation methods and strategies for proteomics","volume":"10","author":"Lee","year":"2010","journal-title":"Proteomics"},{"issue":"17","key":"10.1016\/j.bcp.2025.117230_b0180","doi-asserted-by":"crossref","first-page":"e4803","DOI":"10.21769\/BioProtoc.4803","article-title":"Endoplasmic reticulum isolation: an optimized approach into cells and mouse liver fractionation","volume":"13","author":"Leiro","year":"2023","journal-title":"Bio-Protoc"},{"key":"10.1016\/j.bcp.2025.117230_b0185","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nprot.2014.016","article-title":"Isolation of plasma membrane-associated membranes from rat liver","volume":"9","author":"Suski","year":"2014","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.bcp.2025.117230_b0190","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/nprot.2009.151","article-title":"Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells","volume":"4","author":"Wieckowski","year":"2009","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.bcp.2025.117230_b0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/mol.118.114934","article-title":"OATP1B3-1B7 (LST-3TM12) is a drug transporter that affects endoplasmic reticulum access and the metabolism of ezetimibe","volume":"96","author":"Malagnino","year":"2019","journal-title":"Mol. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:03:49Z","timestamp":1762481029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225004952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":39,"alternative-id":["S0006295225004952"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117230","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of organic anion transporter 2 in the efflux of raltegravir glucuronide from the endoplasmic reticulum in the liver","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117230"}}